Vestal Point Capital, LP: holdings and changes
Number 63 of the top 100 funds by copy return. Vestal Point Capital, LP reported 63 US stocks worth $3.9B for the quarter ending 2026-09-30 and changed 15 new, 22 added, 19 trimmed and 20 sold since 2026-06-30.
Copy return, 4 quarters+43.4%
US 500, same time+14.5%
Size$3.9B
Stocks63
Holdings
| Stock | Change | Weight | Value | Shares |
|---|---|---|---|---|
| ABVX Abivax Sa-Adr | ADD +69% | 10.13% | $392M | 3,960,000 |
| NBIX Neurocrine Biosciences INC | ADD +33% | 9.16% | $355M | 2,500,000 |
| BMRN Biomarin Pharmaceutical INC | TRIM -8% | 8.56% | $332M | 5,525,000 |
| ARWR Arrowhead Pharmaceuticals, INC. | ADD +206% | 8.14% | $315M | 4,815,000 |
| INSM Insmed INC. | ADD +990% | 8.04% | $311M | 2,725,000 |
| UTHR United Therapeutics Corp | ADD +9% | 6.65% | $257M | 475,000 |
| ASND Ascendis Pharma A/S | ADD +97% | 4.36% | $169M | 740,000 |
| NRIX Nurix Therapeutics INC | TRIM -13% | 4.30% | $167M | 7,025,000 |
| TARS Tarsus Pharmaceuticals INC | ADD +94% | 4.13% | $160M | 2,033,625 |
| ELVN Enliven Therapeutics INC | TRIM -19% | 3.82% | $148M | 3,225,000 |
| IRON Disc Medicine INC | ADD +5% | 2.77% | $107M | 1,635,000 |
| BCAX Bicara Thera INC | ADD +5% | 2.66% | $103M | 5,525,000 |
| DYN Dyne Therapeutics INC | ADD +84% | 2.58% | $100M | 6,200,000 |
| IMTX Immatics N.V | ADD +81% | 2.54% | $98M | 11,200,000 |
| TSHA Taysha Gene Therapies INC Com Shs | TRIM -7% | 2.27% | $88M | 18,045,000 |
| GLUE Monte Rosa Therapeutics INC | ADD +55% | 2.20% | $85M | 7,130,000 |
| GMED Globus Med INC Cl A | ADD +8% | 1.77% | $68M | 915,000 |
| CBIO Crescent Biopharma INC. | ADD +84% | 1.13% | $44M | 3,000,000 |
| ZBH Zimmer Hldgs INC Com | TRIM -66% | 1.09% | $42M | 475,000 |
| TVTX Travere Therapeutics INC | BUY | 0.91% | $35M | 600,000 |
| RCUS Arcus Biosciences INC | BUY | 0.87% | $34M | 1,300,000 |
| XENE Xenon Pharmaceuticals INC | ADD +21% | 0.82% | $32M | 850,000 |
| NKTR Nektar Therapeutics | TRIM -49% | 0.80% | $31M | 510,000 |
| DRUG Bright Minds Biosciences INC | 0.70% | $27M | 545,000 | |
| BBIO Bridgebio Pharma INC | BUY | 0.68% | $26M | 400,000 |
| IMCR Immunocore Holdings Limited | TRIM -53% | 0.67% | $26M | 850,000 |
| PODD Insulet Corp | TRIM -74% | 0.59% | $23M | 175,000 |
| TRVI Trevi Therapeutics | TRIM -52% | 0.55% | $21M | 1,495,000 |
| SNY Sanofi Adr | TRIM -75% | 0.53% | $21M | 500,000 |
| SVRA Savara INC | ADD +21% | 0.44% | $17M | 3,300,000 |
| SGP Spyglass Pharma INC | TRIM -4% | 0.43% | $17M | 640,000 |
| ZYME Zymeworks INC | BUY | 0.41% | $16M | 600,000 |
| COGT Cogent Biosciences INC | BUY | 0.39% | $15M | 475,000 |
| SLDB Solid Biosciences INC | TRIM -3% | 0.39% | $15M | 2,085,000 |
| LXEO Lexeo Therapeutics INC | 0.38% | $15M | 4,320,000 | |
| AVTX Avalo Therapeutics INC | ADD +3% | 0.32% | $12M | 800,000 |
| ZBIO Zenas Biopharma INC | ADD +8% | 0.28% | $11M | 395,000 |
| EVMN Evommune INC | ADD +25% | 0.27% | $10M | 1,250,000 |
| VKTX Viking Therapeutics INC | TRIM -57% | 0.24% | $10M | 290,000 |
| STOK Stoke Therapeutics INC | BUY | 0.23% | $9M | 345,000 |
| KRSA Korsana Biosciences INC | BUY | 0.22% | $8M | 263,105 |
| DMRA Damora Therapeutics INC Com Shs | BUY | 0.22% | $8M | 395,000 |
| TECX Tectonic Therapeutic INC | TRIM -15% | 0.22% | $8M | 360,000 |
| ZURA Zura Bio LTD | ADD +58% | 0.20% | $8M | 1,860,000 |
| GKOS Glaukos Corp | BUY | 0.19% | $7M | 45,000 |
| KLRA Kailera Therapeutics INC | ADD +9% | 0.18% | $7M | 625,000 |
| AVR Anteris Technologies Global | TRIM -16% | 0.17% | $7M | 850,000 |
| MLTX Moonlake Immunot | BUY | 0.16% | $6M | 525,000 |
| RZLT Rezolute INC | ADD +280% | 0.16% | $6M | 1,455,000 |
| TRAX First Tracks Biotherapeutics | TRIM -83% | 0.16% | $6M | 169,738 |
| VYGR Voyager Therapeutics INC | TRIM -18% | 0.15% | $6M | 2,165,000 |
| MAZE Maze Therapeutics | BUY | 0.12% | $5M | 175,000 |
| OLEMA PHARMACE Olema Pharmaceut | 0.09% | $4M | 420,000 | |
| PALI Palisade Bio INC | 0.09% | $3M | 2,500,000 | |
| ENGN Engene Therapeut | 0.09% | $3M | 1,665,000 | |
| NGNE Neurogene INC Com | BUY | 0.08% | $3M | 115,000 |
| IBIO Ibio INC | 0.08% | $3M | 2,600,000 | |
| AVBP Arrivent Biopharma INC | BUY | 0.08% | $3M | 100,000 |
| OKUR Onkure Therapeutics INC | TRIM -40% | 0.08% | $3M | 1,088,000 |
| CTMX Cytomx Therapeutics INC | BUY | 0.04% | $2M | 535,000 |
| OCS Oculis Holding Ag | BUY | 0.03% | $1M | 132,000 |
| NYXOAH SA NPV Nyxoah Sa Npv Isin Be0974358906 Sedol Bn | TRIM -43% | 0.02% | $700k | 479,000 |
| APRE Aprea Therapeutics INC | 0.01% | $300k | 350,000 | |
| Abbot Labs Abbot Labs | SELL | 0% | was $127M | 0 |
| Astrazeneca Pl Astrazeneca PLC Ord | SELL | 0% | was $85M | 0 |
| RVMD Revolution Medicines INC | SELL | 0% | was $84M | 0 |
| BCRX Biocryst Pharmaceuticals INC | SELL | 0% | was $83M | 0 |
| RGEN Repligen INC. | SELL | 0% | was $55M | 0 |
| BMY Bristol Myers Squibb Co | SELL | 0% | was $46M | 0 |
| QURE Uniqure Nv | SELL | 0% | was $43M | 0 |
| MDGL Madrigal Pharmaceuticals INC | SELL | 0% | was $35M | 0 |
| ALC Alcon INC | SELL | 0% | was $34M | 0 |
| MYGN Myriad Genetics | SELL | 0% | was $33M | 0 |
| RAPP Rapport Therapeutics INC | SELL | 0% | was $30M | 0 |
| GEHC Ge Healthcare Technologies I | SELL | 0% | was $29M | 0 |
| BBNX Beta Bionics INC | SELL | 0% | was $25M | 0 |
| REGN Regeneron Pharmaceuticals INC Com | SELL | 0% | was $25M | 0 |
| ANRO Alto Neuroscience INC | SELL | 0% | was $21M | 0 |
| GALECTO INC Galecto INC | SELL | 0% | was $15M | 0 |
| SRZN Surrozen INC | SELL | 0% | was $8M | 0 |
| MNPR Monopar Therapeutics INC | SELL | 0% | was $7M | 0 |
| SGMT Sagimet Biosciences INC. | SELL | 0% | was $4M | 0 |
| TENX Tenax Therapeutics INC | SELL | 0% | was $800k | 0 |
Copy return each quarter
| Held | Fund copy | US 500 |
|---|---|---|
| 2024-03-31 → 2024-06-30 | +1.0% | +4.0% |
| 2024-06-30 → 2024-09-30 | +5.7% | +5.4% |
| 2024-09-30 → 2024-12-31 | -3.3% | +2.1% |
| 2024-12-31 → 2025-03-31 | -8.5% | -4.6% |
| 2025-03-31 → 2025-06-30 | -0.1% | +10.5% |
| 2025-06-30 → 2025-09-30 | +42.7% | +7.8% |
| 2025-09-30 → 2025-12-31 | +27.6% | +2.4% |
| 2025-12-31 → 2026-03-31 | +7.3% | -4.6% |
| 2026-03-31 → 2026-06-30 | +14.6% | +14.8% |
| 2026-06-30 → 2026-09-30 | -8.6% | +2.1% |
The copy return buys the fund's reported stocks on the day after the filing became public and holds them for one quarter, so it measures what anyone reading the filings could have done.
All top 100 funds, liveOther top funds
Nextech Invest LTD.Venrock Adviser, LLCFairmount Funds Management LLCTalos Eurisko Asset Management LPAnalog Century Management LPQvt Financial LPBroad Peak Investment Advisers Pte LTDWs Management LllpBvf INC/IlParadigm Biocapital Advisors LPOak Grove Capital LLCCm Wealth Advisors LLCAvidity Partners Management LPFirst Light Asset Management, LLCLogos Global Management LPSummit Street Capital Management, LLCMadison Avenue Partners, LPDivisar Capital Management LLCTcg Crossover Management, LLCOptimus Prime Fund Management Co., LTD.Value Aligned Research Advisors, LLCBraidwell LPRedmile Group, LLCOrbimed Advisors LLCMpm Bioimpact LLCCloudalpha Capital Management Limited/Hong KongGeneral Pension Society Pzu Joint Stock CoAmanah Holdings TrustSlate Path Capital LPDeep Track Capital, LP